Treatment of Aggressive Pituitary Adenomas: A Case-Based Narrative Review.
aggressive adenomas
pituitary adenomas
radiation therapy
surgery
targeted therapy
temozolomide
Journal
Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782
Informations de publication
Date de publication:
2021
2021
Historique:
received:
14
06
2021
accepted:
28
10
2021
entrez:
6
12
2021
pubmed:
7
12
2021
medline:
12
2
2022
Statut:
epublish
Résumé
Management of aggressive pituitary adenomas is challenging due to a paucity of rigorous evidence supporting available treatment approaches. Recent guidelines emphasize the need to maximize standard therapies as well as the use of temozolomide and radiation therapy to treat disease recurrence. However, often these adenomas continue to progress over time, necessitating the use of additional targeted therapies which also impact quality of life and long-term outcomes. In this review, we present 9 cases of aggressive pituitary adenomas to illustrate the importance of a multidisciplinary, individualized approach. The timing and rationale for surgery, radiation therapy, temozolomide, somatostatin receptor ligands, and EGFR, VEGF, and mTOR inhibitors in each case are discussed within the context of evidence-based guidelines and clarify strategies for implementing an individualized approach in the management of these difficult-to-treat-adenomas.
Identifiants
pubmed: 34867776
doi: 10.3389/fendo.2021.725014
pmc: PMC8634600
doi:
Types de publication
Case Reports
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
725014Informations de copyright
Copyright © 2021 Cooper, Bonert, Liu and Mamelak.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Endocrine. 2018 Aug;61(2):343-348
pubmed: 29948930
J Clin Endocrinol Metab. 2019 Jun 1;104(6):1929-1936
pubmed: 30624667
J Endocrinol Invest. 2020 Nov;43(11):1543-1553
pubmed: 32557353
Nat Genet. 2015 Jan;47(1):31-8
pubmed: 25485838
Pituitary. 2020 Aug;23(4):359-366
pubmed: 32232709
J Neurooncol. 2018 Jun;138(2):335-340
pubmed: 29450811
Eur J Endocrinol. 2019 Aug;181(2):K21-K27
pubmed: 31167168
World Neurosurg. 2020 Apr;136:374-381.e4
pubmed: 31899390
Int J Cancer. 2017 May 1;140(9):2150-2161
pubmed: 28152577
J Clin Endocrinol Metab. 2017 Nov 1;102(11):4284-4291
pubmed: 28938462
J Neurooncol. 2019 Nov;145(2):301-307
pubmed: 31541405
Endocr Relat Cancer. 2011 Oct 27;18(6):R197-211
pubmed: 21917845
J Clin Med. 2019 Jul 25;8(8):
pubmed: 31349718
F1000Res. 2016 Sep 08;5:
pubmed: 27635238
Endocr Relat Cancer. 2007 Mar;14(1):91-102
pubmed: 17395978
Clin Endocrinol (Oxf). 2018 Jun 29;:
pubmed: 29957855
J Neurooncol. 2016 Feb;126(3):519-25
pubmed: 26614517
Pituitary. 2012 Mar;15(1):71-83
pubmed: 21918830
Neuroendocrinology. 2006;83(3-4):230-9
pubmed: 17047388
J Clin Endocrinol Metab. 2015 Jul;100(7):E997-1004
pubmed: 25942478
Pituitary. 2012 Dec;15(4):571-8
pubmed: 22207350
Int J Radiat Oncol Biol Phys. 1992;24(2):307-14
pubmed: 1526869
CNS Oncol. 2016 Oct;5(4):203-9
pubmed: 27615706
Eur J Endocrinol. 2017 Jun;176(6):769-777
pubmed: 28432119
Eur J Endocrinol. 1999 Oct;141(4):396-408
pubmed: 10526255
N Engl J Med. 2020 Mar 5;382(10):937-950
pubmed: 32130815
Eur J Endocrinol. 2018 Sep;179(3):191-198
pubmed: 29973377
Best Pract Res Clin Endocrinol Metab. 2019 Apr;33(2):101269
pubmed: 31053487
J Clin Endocrinol Metab. 2006 May;91(5):1796-801
pubmed: 16507632
J Clin Med. 2020 Sep 22;9(9):
pubmed: 32971845
Nat Rev Endocrinol. 2011 May;7(5):279-89
pubmed: 21301487
Eur J Endocrinol. 2008 May;158(5):595-603
pubmed: 18426817
J Clin Endocrinol Metab. 2021 Jan 23;106(2):e917-e925
pubmed: 33150390
J Clin Endocrinol Metab. 2015 Aug;100(8):2807-31
pubmed: 26222757
Exp Clin Endocrinol Diabetes. 2021 Mar;129(3):178-185
pubmed: 33285600
J Neurooncol. 2015 Mar;122(1):189-96
pubmed: 25555563
J Clin Neurosci. 2017 Jul;41:75-77
pubmed: 28291643
J Clin Endocrinol Metab. 2010 Nov;95(11):E280-90
pubmed: 20668043
Neurooncol Pract. 2016 Sep;3(3):188-195
pubmed: 27551432
Int J Endocrinol. 2014;2014:608497
pubmed: 25505910
J Clin Invest. 2011 Dec;121(12):4712-21
pubmed: 22105169
Front Endocrinol (Lausanne). 2019 Nov 14;10:785
pubmed: 31798535
Endocrine. 2014 Jun;46(2):318-27
pubmed: 24287797
Endocr Relat Cancer. 2019 Aug;26(9):R545-R552
pubmed: 31311005
J Neurosurg. 2005 Apr;102(4):678-91
pubmed: 15871511
J Clin Endocrinol Metab. 2008 Dec;93(12):4721-7
pubmed: 18812485
J Clin Endocrinol Metab. 2020 Mar 1;105(3):
pubmed: 31746334
Cell Res. 2015 Mar;25(3):306-17
pubmed: 25675982
Rev Endocr Metab Disord. 2020 Jun;21(2):263-276
pubmed: 32147777
J Clin Endocrinol Metab. 2013 May;98(5):1803-7
pubmed: 23539733
Eur J Endocrinol. 2019 Oct;181(4):397-407
pubmed: 31349217
World Neurosurg. 2019 Feb;122:417-423
pubmed: 30447452
Neurosurgery. 2003 Feb;52(2):309-16; discussion 316-7
pubmed: 12535358
Pituitary. 2010;13(1):68-77
pubmed: 19697135
Pituitary. 2013 Sep;16(3):393-401
pubmed: 23011322
J Neurosurg. 2019 Jun 14;:1-8
pubmed: 31200381
Endocr Relat Cancer. 2008 Dec;15(4):905-15
pubmed: 18780796
Eur J Endocrinol. 2019 Aug;181(2):C1-C3
pubmed: 31167164
J Clin Endocrinol Metab. 2010 Feb;95(2):968-76
pubmed: 19965918
J Neurosurg. 1995 Apr;82(4):536-47
pubmed: 7897512
Pituitary. 2018 Jun;21(3):247-255
pubmed: 29313180
Eur J Endocrinol. 2009 Oct;161(4):631-7
pubmed: 19654234
J Clin Endocrinol Metab. 1998 Oct;83(10):3419-26
pubmed: 9768641
J Clin Endocrinol Metab. 2021 Mar 8;106(3):826-842
pubmed: 33221858
J Clin Endocrinol Metab. 2011 Feb;96(2):273-88
pubmed: 21296991
Pituitary. 2017 Oct;20(5):489-498
pubmed: 28884415
J Neurooncol. 2014 May;117(3):445-57
pubmed: 24122025
Cancer Res. 2009 May 15;69(10):4209-16
pubmed: 19401448
J Clin Endocrinol Metab. 2017 Aug 1;102(8):2836-2843
pubmed: 28505279
Endocr Rev. 2015 Aug;36(4):385-486
pubmed: 26067718
Eur J Endocrinol. 2018 Jan;178(1):G1-G24
pubmed: 29046323
Horm Metab Res. 2019 Dec;51(12):755-764
pubmed: 31826270
Pituitary. 2015 Apr;18(2):274-8
pubmed: 25612787
Eur J Endocrinol. 2018 Mar;178(3):265-276
pubmed: 29330228
J Neurosurg. 2018 Aug;129(2):404-416
pubmed: 28862548
J Neurosurg. 2005 Jun;102(6):1004-12
pubmed: 16028758
Mol Endocrinol. 2011 Jan;25(1):92-103
pubmed: 21106881
J Clin Endocrinol Metab. 2020 May 1;105(5):
pubmed: 31735971
Endocr J. 2003 Oct;50(5):635-42
pubmed: 14614221
Eur J Clin Invest. 2011 Oct;41(10):1133-48
pubmed: 21496012
Mol Cancer. 2006 Dec 02;5:67
pubmed: 17140455
Acta Neuropathol. 2017 Oct;134(4):521-535
pubmed: 28821944
Pituitary. 2012 Sep;15(3):445-9
pubmed: 21918831
Clin Endocrinol (Oxf). 2002 Apr;56(4):541-51
pubmed: 11966748
J Clin Med. 2019 Dec 21;9(1):
pubmed: 31877737
Clin Transl Oncol. 2018 Oct;20(10):1233-1245
pubmed: 29623588
J Clin Oncol. 2013 Nov 10;31(32):4085-91
pubmed: 24101040
Eur J Endocrinol. 2016 Feb;174(2):213-26
pubmed: 26578638
J Clin Endocrinol Metab. 2015 Apr;100(4):1689-98
pubmed: 25646794
Pituitary. 2016 Dec;19(6):605-611
pubmed: 27639583
Neuro Oncol. 2019 Oct 9;21(10):1273-1283
pubmed: 31222332
Endocr Pathol. 2019 Jun;30(2):118-127
pubmed: 30706322
Pituitary. 2012 Sep;15(3):276-87
pubmed: 22076588
Endocr Pathol. 1998 Spring;9(1):53-62
pubmed: 12114662
N Engl J Med. 2005 Mar 10;352(10):987-96
pubmed: 15758009
Neurosurgery. 2014 Apr;74(4):E447-55; discussion E455
pubmed: 24226425
Int J Clin Exp Med. 2015 Aug 15;8(8):12898-905
pubmed: 26550206
Eur J Endocrinol. 2007 Feb;156(2):217-24
pubmed: 17287411